7.7555
전일 마감가:
$8.10
열려 있는:
$7.87
하루 거래량:
2.00M
Relative Volume:
1.56
시가총액:
$1.05B
수익:
$53.61M
순이익/손실:
$-142.52M
주가수익비율:
-6.9869
EPS:
-1.11
순현금흐름:
$-141.83M
1주 성능:
+13.59%
1개월 성능:
+28.66%
6개월 성능:
-43.94%
1년 성능:
+26.36%
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
WVE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
WVE
Wave Life Sciences Ltd
|
7.75 | 1.05B | 53.61M | -142.52M | -141.83M | -1.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.99 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.54 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
653.91 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
271.25 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
2025-04-08 | 개시 | Wedbush | Outperform |
2025-02-25 | 개시 | Jefferies | Buy |
2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-09-27 | 재개 | JP Morgan | Overweight |
2024-09-19 | 개시 | B. Riley Securities | Buy |
2024-09-09 | 개시 | JP Morgan | Overweight |
2024-05-15 | 개시 | Wells Fargo | Overweight |
2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2023-07-05 | 개시 | Raymond James | Outperform |
2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
2020-12-15 | 재개 | H.C. Wainwright | Buy |
2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | 개시 | Guggenheim | Buy |
2019-07-15 | 개시 | Cowen | Market Perform |
2019-04-17 | 재확인 | H.C. Wainwright | Buy |
2018-08-07 | 개시 | Stifel | Buy |
2018-07-23 | 개시 | H.C. Wainwright | Buy |
2018-03-19 | 재확인 | Mizuho | Buy |
2017-02-15 | 개시 | H.C. Wainwright | Buy |
2016-11-10 | 재개 | Leerink Partners | Outperform |
2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
2015-12-07 | 개시 | Jefferies | Buy |
2015-12-07 | 개시 | Leerink Partners | Outperform |
2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Renaissance Technologies LLC Lowers Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Invesco Ltd. Increases Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wells Fargo & Company MN Purchases 22,873 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
WVE Shares Experience Surge in Value - knoxdaily.com
Cantor Fitzgerald Predicts WVE FY2025 Earnings - Defense World
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Wave Life Sciences to Host Webcast for First Quarter 2025 Financial Results and Business Updates - Nasdaq
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 - GlobeNewswire
RNA Medicine Pioneer Wave Life Sciences Sets Q1 2025 Earnings Call for May 8 - Stock Titan
Cantor Fitzgerald Initiates Coverage on Wave Life Sciences (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) Stock: From Low to High in 52 Weeks - investchronicle.com
Wave Life Sciences Ltd (NASDAQ: WVE): Why Investors Shouldn’t Ditch WVE Stock In 2025 - Marketing Sentinel
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts - Benzinga
Wave Life Sciences Ltd (WVE) looking to reclaim success with recent performance - Sete News
Cantor Fitzgerald sets WAVE Life Sciences stock at Overweight By Investing.com - Investing.com India
Cantor Fitzgerald Initiates Wave Life Sciences at Overweight With $10 Price Target - marketscreener.com
Wave Life Sciences (WVE) Receives Overweight Rating and $10 Pric - GuruFocus
Wedbush analysts initates an Outperform rating for Wave Life Sciences Ltd (WVE) - knoxdaily.com
Can you now get a good deal on Wave Life Sciences Ltd’s shares? - uspostnews.com
Check Out Wave Life Sciences Ltd (WVE)’s Trade Data Rather Than the Analysts’ Views - Sete News
Analysts Say Wave Life Sciences Ltd (NASDAQ:WVE) Can Really Get To 36 In 12 Months - Marketing Sentinel
A stock that deserves closer examination: Wave Life Sciences Ltd (WVE) - uspostnews.com
Daily Market Movement: Wave Life Sciences Ltd (WVE) Sees a 3.51 Increase, Closing at 6.79 - DWinneX
Russell Investments Group Ltd. Purchases 43,398 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) rating initates by Wedbush - knoxdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of “Buy” by Brokerages - Defense World
(WVE) Investment Report - news.stocktradersdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - Defense World
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Franklin Resources Inc. Trims Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Raised by Geode Capital Management LLC - Defense World
Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely? - Yahoo
Vanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid FDA Timeline Concerns | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Price Target Reduced by B. Riley Amid F - GuruFocus
B. Riley Adjusts Wave Life Sciences' Price Target to $19 From $22, Keeps Buy Rating - MarketScreener
Wave Life Sciences (NASDAQ:WVE) Coverage Initiated by Analysts at Wedbush - Defense World
Wedbush sets $18 target for WAVE Life Sciences stock By Investing.com - Investing.com India
Wedbush sets $18 target for WAVE Life Sciences stock - Investing.com Australia
Wedbush Initiates Wave Life Sciences at Outperform With $18 Price Target - marketscreener.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Sei Investments Co. - Defense World
KLP Kapitalforvaltning AS Acquires New Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
(WVE) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 41% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $10 From $14, Keeps Sector Perform, Speculative Risk - MarketScreener
Wave Life Sciences’ SWOT analysis: RNA editing pioneer faces challenges in genetic medicine stock - Investing.com India
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance
What is Leerink Partnrs’ Estimate for WVE Q1 Earnings? - Defense World
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance
HC Wainwright Reaffirms “Buy” Rating for Wave Life Sciences (NASDAQ:WVE) - Defense World
Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531 (NASDAQ:WVE) - Seeking Alpha
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Wave Life Sciences Ltd 주식 (WVE) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
HENRY CHRISTIAN O | Director |
Mar 20 '25 |
Sale |
9.77 |
10,500 |
102,574 |
16,115 |
자본화:
|
볼륨(24시간):